Genomic profiling of mitochondrion-rich breast carcinoma: Chromosomal changes may be relevant for mitochondria accumulation and tumour biology

Breast Cancer Research and Treatment

Volumn 132, Issue 1, 2012, Pages 15-28

  Geyer, Felipe C ^a   De Biase, Dario ^a,b   Lambros, Maryou B K ^a   Ragazzi, Moira ^b   Lopez Garcia, Maria A ^a,c   Natrajan, Rachael ^a   Mackay, Alan ^a   Kurelac, Ivana ^d   Gasparre, Giuseppe ^d   Ashworth, Alan ^a   Eusebi, Vincenzo ^b   Reis Filho, Jorge S ^a   Tallini, Giovanni ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

aCGH; Breast cancer; Chromosomal DNA; Microarray; Mitochondria; Oncocytic tumours

Indexed keywords

ANDROGEN RECEPTOR; CD68 ANTIGEN; CHROMOGRANIN; CYTOKERATIN 14; CYTOKERATIN 7; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITHELIAL MEMBRANE ANTIGEN; ESTROGEN RECEPTOR; KI 67 ANTIGEN; MITOCHONDRIAL DNA; MITOCHONDRION ANTIBODY; PROGESTERONE RECEPTOR; PROTEIN GCDFP 15; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CHROMOSOME ABERRATION; CHROMOSOME MICRODISSECTION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA EXTRACTION; GENE DOSAGE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; INVASIVE CARCINOMA; MICROARRAY ANALYSIS; MOLECULAR BIOLOGY; PRIORITY JOURNAL; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, DUCTAL, BREAST; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; HUMANS; MIDDLE AGED; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; NEOPLASM GRADING; PHENOTYPE; RECEPTORS, ESTROGEN;

EID: 84857844374     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1504-4     Document Type: Article

References (58)

1. Tallini G (1998) Oncocytic tumours. Virchows Arch 433(1):5-12
2. Costa MJ, Silverberg SG (1989) Oncocytic carcinoma of the male breast. Arch Pathol Lab Med 113(12):1396-1399 (Pubitemid 20027939)
3. Damiani S, Eusebi V, Losi L, D'Adda T, Rosai J (1998) Oncocytic carcinoma (malignant oncocytoma) of the breast. Am J Surg Pathol 22(2):221-230 (Pubitemid 28113384)
4. Hamperl H (1972) Oncocyten und hyaline einschlusse in der menschlischen mamma. Virchows Arch 10:88-92
5. Ragazzi M, de Biase D, Betts CM, Farnedi A, Ramadan SS, Tallini G, Reis-Filho JS, Eusebi V (2010) Oncocytic carcinoma of the breast: frequency, morphology and follow up. Human Pathol 42(2):166-175
6. Tavassoli FA, Devilee P (eds) (2003) Tumours of the breast. Pathology and genetics. Tumours of the breast and female genital organs. International Agency for Research of Cancer (IARC), Lyon
7. Damiani S, Dina R, Eusebi V (1999) Eosinophilic and granular cell tumors of the breast. Semin Diagn Pathol 16(2):117-125 (Pubitemid 29357969)
8. Gasparre G, Porcelli AM, Bonora E, Pennisi LF, Toller M, Iommarini L, Ghelli A, Moretti M, Betts CM, Martinelli GN, Ceroni AR, Curcio F, Carelli V, Rugolo M, Tallini G, Romeo G (2007) Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors. Proc Natl Acad Sci USA 104(21):9001-9006 (Pubitemid 47175426)
9. Solis LM, Raso MG, Kalhor N, Behrens C, Wistuba II, Moran CA (2010) Primary oncocytic adenocarcinomas of the lung: a clinicopathologic, immunohistochemical, and molecular biologic analysis of 16 cases. Am J Clin Pathol 133(1):133-140
10. Sheu SY, Handke S, Brocker-Preuss M, Gorges R, Frey UH, Ensinger C, Ofner D, Farid NR, Siffert W, Schmid KW (2007) The C allele of the GNB3 C825T polymorphism of the G protein beta3-subunit is associated with an increased risk for the development of oncocytic thyroid tumours. J Pathol 211(1):60-66 (Pubitemid 46092030)
11. Jhang JS, Narayan G, Murty VV, Mansukhani MM (2004) Renal oncocytomas with 11q13 rearrangements: cytogenetic, molecular, and immunohistochemical analysis of cyclin D1. Cancer Genet Cytogenet 149(2):114-119 (Pubitemid 38293028)
12. Sukov WR, Ketterling RP, Lager DJ, Carlson AW, Sinnwell JP, Chow GK, Jenkins RB, Cheville JC (2009) CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma. Hum Pathol 40(9): 1296-1303
13. Gasparre G, Bonora E, Tallini G, Romeo G (2010) Molecular features of thyroid oncocytic tumors. Mol Cell Endocrinol 321(1): 67-76
14. Bonora E, Porcelli AM, Gasparre G, Biondi A, Ghelli A, Carelli V, Baracca A, Tallini G, Martinuzzi A, Lenaz G, Rugolo M, Romeo G (2006) Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III. Cancer Res 66(12):6087-6096
15. Canzian F, Amati P, Harach HR, Kraimps JL, Lesueur F, Barbier J, Levillain P, Romeo G, Bonneau D (1998) A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 63(6):1743-1748 (Pubitemid 30415737)
16. Lewis PD, Baxter P, Paul Griffiths A, Parry JM, Skibinski DO (2000) Detection of damage to the mitochondrial genome in the oncocytic cells of Warthin's tumour. J Pathol 191(3):274-281 (Pubitemid 30441251)
17. Lewis PD, Baxter PW, Griffiths AP, Parry JM, Skibinski DO (2000) Authors' reply. Mitochondrial DNA damage and oncocytic neoplasia. J Pathol 192(4):562-563
18. Maximo V, Botelho T, Capela J, Soares P, Lima J, Taveira A, Amaro T, Barbosa AP, Preto A, Harach HR, Williams D, Sobrinho- Simoes M (2005) Somatic and germline mutation in GRIM- 19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid. Br J Cancer 92(10):1892-1898 (Pubitemid 40826138)
19. Maximo V, Sobrinho-Simoes M (2000) Mitochondrial DNA 'common' deletion in Hurthle cell lesions of the thyroid. J Pathol 192(4):561-562
20. Neuhaus C, Dijkhuizen T, van den Berg E, Storkel S, Stockle M, Mensch B, Huber C, Decker HJ (1997) Involvement of the chromosomal region 11q13 in renal oncocytoma: case report and literature review. Cancer Genet Cytogenet 94(2):95-98 (Pubitemid 27169339)
21. Wada N, Duh QY, Miura D, Brunaud L, Wong MG, Clark OH (2002) Chromosomal aberrations by comparative genomic hybridization in hurthle cell thyroid carcinomas are associated with tumor recurrence. J Clin Endocrinol Metab 87(10):4595-4601 (Pubitemid 35247046)
22. Ambrosini-Spaltro A, Salvi F, Betts CM, Frezza GP, Piemontese A, Del Prete P, Baldoni C, Foschini MP, Viale G (2006) Oncocytic modifications in rectal adenocarcinomas after radio and chemotherapy. Virchows Arch 448(4):442-448
23. Sobrinho-Simoes M, Maximo V, Castro IV, Fonseca E, Soares P, Garcia-Rostan G, Oliveira MC (2005) Hurthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance. Int J Surg Pathol 13(1):29-35 (Pubitemid 40224094)
24. Sinke RJ, Dijkhuizen T, Janssen B, Olde Weghuis D, Merkx G, van den Berg E, Schuuring E, Meloni AM, de Jong B, Geurts van Kessel A (1997) Fine mapping of the human renal oncocytoma-associated translocation (5;11)(q35;q13) breakpoint. Cancer Genet Cytogenet 96(2):95-101 (Pubitemid 27287480)
25. Maximo V, Soares P, Lima J, Cameselle-Teijeiro J, Sobrinho- Simoes M (2002) Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hurthle cell tumors. Am J Pathol 160(5):1857-1865. doi:10.1016/S0002-9440(10)61132-7 (Pubitemid 34525665)
26. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19(5):403-410
27. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thurlimann B, Senn HJ (2005) Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 16(10):1569-1583 (Pubitemid 41511089)
28. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25(1):118-145 (Pubitemid 350003059)
29. Marchio C, Iravani M, Natrajan R, Lambros MB, Savage K, Tamber N, Fenwick K, Mackay A, Senetta R, Di Palma S, Schmitt FC, Bussolati G, Ellis LO, Ashworth A, Sapino A, Reis- Filho JS (2008) Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast. J Pathol 215(4):398-410
30. Geyer FC, Weigelt B, Natrajan R, Lambros MB, de Biase D, Vatcheva R, Savage K, Mackay A, Ashworth A, Reis-Filho JS (2010) Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas. J Pathol 220(5):562-573
31. Loo LW, Grove DI, Williams EM, Neal CL, Cousens LA, Schubert EL, Holcomb IN, Massa HF, Glogovac J, Li CI, Malone KE, Daling JR, Delrow JJ, Trask BJ, Hsu L, Porter PL (2004) Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes. Cancer Res 64(23):8541-8549 (Pubitemid 39552066)
32. Melchor L, Honrado E, Huang J, Alvarez S, Naylor TL, Garcia MJ, Osorio A, Blesa D, Stratton MR, Weber BL, Cigudosa JC, Rahman N, Nathanson KL, Benitez J (2007) Estrogen receptor status could modulate the genomic pattern in familial and sporadic breast cancer. Clin Cancer Res 13(24):7305-7313
33. Natrajan R, Lambros MB, Geyer FC, Marchio C, Tan DS, Vatcheva R, Shiu KK, Hungermann D, Rodriguez-Pinilla SM, Palacios J, Ashworth A, Buerger H, Reis-Filho JS (2009) Loss of 16q in high grade breast cancer is associated with estrogen receptor status: evidence for progression in tumors with a luminal phenotype? Genes Chromosomes Cancer 48(4):351-365
34. Natrajan R, Lambros MB, Rodriguez-Pinilla SM, Moreno-Bueno G, Tan DS, Marchio C, Vatcheva R, Rayter S, Mahler-Araujo B, Fulford LG, Hungermann D, Mackay A, Grigoriadis A, Fenwick K, Tamber N, Hardisson D, Tutt A, Palacios J, Lord CJ, Buerger H, Ashworth A, Reis-Filho JS (2009) Tiling path genomic profiling of grade 3 invasive ductal breast cancers. Clin Cancer Res 15(8):2711-2722
35. Geyer FC, Lopez-Garcia MA, Lambros MB, Reis-Filho JS (2009) Genetic characterization of breast cancer and implications for clinical management. J Cell Mol Med 13(10):4090-4103
36. Weigelt B, Baehner FL, Reis-Filho JS (2010) The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade. J Pathol 220(2):263-280
37. Marchio C, Iravani M, Natrajan R, Lambros MB, Geyer FC, Savage K, Parry S, Tamber N, Fenwick K, Mackay A, Schmitt FC, Bussolati G, Ellis I, Ashworth A, Sapino A, Reis-Filho JS (2009) Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components. J Pathol 218(3):301-315
38. Coe BP, Ylstra B, Carvalho B, Meijer GA, Macaulay C, Lam WL (2007) Resolving the resolution of array CGH. Genomics 89(5):647-653 (Pubitemid 46589944)
39. Gunnarsson R, Staaf J, Jansson M, Ottesen AM, Goransson H, Liljedahl U, Ralfkiaer U, Mansouri M, Buhl AM, Smedby KE, Hjalgrim H, Syvanen AC, Borg A, Isaksson A, Jurlander J, Juliusson G, Rosenquist R (2008) Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia-a comparative study of four differently designed, high resolution microarray platforms. Genes Chromosomes Cancer 47(8):697-711 (Pubitemid 351847582)
40. Tan DS, Lambros MB, Natrajan R, Reis-Filho JS (2007) Getting it right: designing microarray (and not 'microawry') comparative genomic hybridization studies for cancer research. Lab Invest 87(8):737-754 (Pubitemid 47077258)
41. Mackay A, Tamber N, Fenwick K, Iravani M, Grigoriadis A, Dexter T, Lord CJ, Reis-Filho JS, Ashworth A (2009) A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell lines. Breast Cancer Res Treat 118(3):481-498
42. Natrajan R, Weigelt B, Mackay A, Geyer FC, Grigoriadis A, Tan DS, Jones C, Lord CJ, Vatcheva R, Rodriguez-Pinilla SM, Palacios J, Ashworth A, Reis-Filho JS (2010) An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers. Breast Cancer Res Treat 121(3):575-589
43. Arriola E, Marchio C, Tan DS, Drury SC, Lambros MB, Natrajan R, Rodriguez-Pinilla SM, Mackay A, Tamber N, Fenwick K, Jones C, Dowsett M, Ashworth A, Reis-Filho JS (2008) Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines. Lab Invest 88(5):491-503 (Pubitemid 351581454)
44. Simpson PT, Reis-Filho JS, Lambros MB, Jones C, Steele D, Mackay A, Iravani M, Fenwick K, Dexter T, Jones A, Reid L, Da Silva L, Shin SJ, Hardisson D, Ashworth A, Schmitt FC, Palacios J, Lakhani SR (2008) Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas. J Pathol 215(3):231-244 (Pubitemid 351956704)
45. Reis-Filho JS, Drury S, Lambros MB, Marchio C, Johnson N, Natrajan R, Salter J, Levey P, Fletcher O, Peto J, Ashworth A, Dowsett M (2008) ESR1 gene amplification in breast cancer: a common phenomenon? Nat Genet 40(7):809-810; author reply 810-802
46. Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F, Ollila DW, Sartor CI, Graham ML, Perou CM (2007) The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 13(8):2329-2334 (Pubitemid 46698581)
47. Hicks J, Krasnitz A, Lakshmi B, Navin NE, Riggs M, Leibu E, Esposito D, Alexander J, Troge J, Grubor V, Yoon S, Wigler M, Ye K, Borresen-Dale AL, Naume B, Schlicting E, Norton L, Hagerstrom T, Skoog L, Auer G, Maner S, Lundin P, Zetterberg A (2006) Novel patterns of genome rearrangement and their association with survival in breast cancer. Genome Res 16(12):1465-1479 (Pubitemid 44878486)
48. Reis-Filho JS, Savage K, Lambros MB, James M, Steele D, Jones RL, Dowsett M (2006) Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis. Mod Pathol 19(7):999-1009
49. Elsheikh S, Green AR, Aleskandarany MA, Grainge M, Paish CE, Lambros MB, Reis-Filho JS, Ellis IO (2008) CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome. Breast Cancer Res Treat 109(2):325-335 (Pubitemid 351644857)
50. Sahin E, Colla S, Liesa M, Moslehi J, Muller FL, Guo M, Cooper M, Kotton D, Fabian AJ, Walkey C, Maser RS, Tonon G, Foerster F, Xiong R, Wang YA, Shukla SA, Jaskelioff M, Martin ES, Heffernan TP, Protopopov A, Ivanova E, Mahoney JE, Kost- Alimova M, Perry SR, Bronson R, Liao R, Mulligan R, Shirihai OS, Chin L, DePinho RA (2011) Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 470(7334):359-365. doi:10.1038/nature09787
51. Burnichon N, Briere JJ, Libe R, Vescovo L, Riviere J, Tissier F, Jouanno E, Jeunemaitre X, Benit P, Tzagoloff A, Rustin P, Bertherat J, Favier J, Gimenez-Roqueplo AP (2010) SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 19(15):3011-3020. doi:10.1093/hmg/ddq206
52. Saada A, Shaag A, Mandel H, Nevo Y, Eriksson S, Elpeleg O (2001) Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 29(3):342-344. doi:10.1038/ng751 (Pubitemid 33096463)
53. Karihtala P, Mantyniemi A, Kang SW, Kinnula VL, Soini Y (2003) Peroxiredoxins in breast carcinoma. Clin Cancer Res 9(9):3418-3424 (Pubitemid 37082738)
54. Shiota M, Izumi H, Miyamoto N, Onitsuka T, Kashiwagi E, Kidani A, Hirano G, Takahashi M, Ono M, Kuwano M, Naito S, Sasaguri Y, Kohno K (2008) Ets regulates peroxiredoxin1 and 5 expressions through their interaction with the high-mobility group protein B1. Cancer Sci 99(10):1950-1959
55. Demasi AP, Furuse C, Altemani A, Junqueira JL, Oliveira PR, Araujo VC (2009) Peroxiredoxin I is overexpressed in oncocytic lesions of salivary glands. J Oral Pathol Med 38(6):514-517
56. Porcelli AM, Ghelli A, Ceccarelli C, Lang M, Cenacchi G, Capristo M, Pennisi LF, Morra I, Ciccarelli E, Melcarne A, Bartoletti-Stella A, Salfi N, Tallini G, Martinuzzi A, Carelli V, Attimonelli M, Rugolo M, Romeo G, Gasparre G (2010) The genetic and metabolic signature of oncocytic transformation implicates HIF1alpha destabilization. Hum Mol Genet 19(6):1019-1032
57. Guerra E, Trerotola M, Dell' Arciprete R, Bonasera V, Palombo B, El-Sewedy T, Ciccimarra T, Crescenzi C, Lorenzini F, Rossi C, Vacca G, Lattanzio R, Piantelli M, Alberti S (2008) A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer. Cancer Res 68(19):8113-8121. doi:10.1158/0008-5472.CAN-07-6135
58. Gasparre G, Romeo G, Rugolo M, Porcelli AM (2010) Learning from oncocytic tumors: why choose inefficient mitochondria? Biochim Biophys Acta. doi:10.1016/j.bbabio.2010.08.006